The estimated Net Worth of Joseph A Carlucci is at least $24.9 Million dollars as of 9 June 2020. Mr. Carlucci owns over 416,720 units of American Renal Associates stock worth over $23,817,582 and over the last 9 years he sold ARA stock worth over $0. In addition, he makes $1,058,800 as Chairman of the Board, Chief Executive Officer, and Co-Founder at American Renal Associates.
Sign up
Mr. Carlucci ARA stock SEC Form 4 insiders trading
Joseph has made over 2 trades of the American Renal Associates stock since 2016, according to the Form 4 filled with the SEC. Most recently he exercised 416,720 units of ARA stock worth $533,402 on 9 June 2020.
The largest trade he's ever made was exercising 416,720 units of American Renal Associates stock on 9 June 2020 worth over $533,402. On average, Joseph trades about 46,358 units every 167 days since 2016. As of 9 June 2020 he still owns at least 662,704 units of American Renal Associates stock.
You can see the complete history of Mr. Carlucci stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Joseph Carlucci biography
Joseph A. Carlucci serves as Chairman of the Board, Chief Executive Officer, Co-Founder of the Company. Mr. Carlucci has more than 37 years of experience in the dialysis services industry. Mr. Carlucci also served as our Chief Operating Officer and Treasurer from our inception in 1999 to 2005. Prior to founding our company, Mr. Carlucci served as President and CEO of Optimal Renal Care, a joint venture between Fresenius Medical Care North America, ("FMCNA"), and Kaiser Permanente of Southern California designed as a disease management organization providing additional opportunities to improve treatment outcomes, improve cost structures, and implement new technologies and methods of dialysis care. Prior to that, Mr. Carlucci served as Vice President of Administration at FMCNA and was responsible nationally for managed care, medical director relations and facility development. He has operations experience from Facility Administrator to Director of U.S. Operations at FMCNA. Mr. Carlucci also serves on the board of directors of Colorado Center for Reproductive Medicine. Mr. Carlucci holds a B.S. degree in Accounting from Bentley University.
What is the salary of Joseph Carlucci?
As the Chairman of the Board, Chief Executive Officer, and Co-Founder of American Renal Associates, the total compensation of Joseph Carlucci at American Renal Associates is $1,058,800. There are 2 executives at American Renal Associates getting paid more, with Don Williamson having the highest compensation of $1,772,140.
How old is Joseph Carlucci?
Joseph Carlucci is 66, he's been the Chairman of the Board, Chief Executive Officer, and Co-Founder of American Renal Associates since 2012. There are 3 older and 8 younger executives at American Renal Associates. The oldest executive at American Renal Associates Holdings Inc. is Robert Fish, 69, who is the Independent Director.
What's Joseph Carlucci's mailing address?
Joseph's mailing address filed with the SEC is C/O ARAH, INC., 500 CUMMINGS CENTER, SUITE 6550, BEVERLY, MA, 01915.
Insiders trading at American Renal Associates
Over the last 9 years, insiders at American Renal Associates have traded over $0 worth of American Renal Associates stock and bought 2,870 units worth $63,140 . The most active insiders traders include Thomas W Erickson, Joseph A Carlucci, and Syed T Kamal. On average, American Renal Associates executives and independent directors trade stock every 215 days with the average trade being worth of $4,293,860. The most recent stock trade was executed by Joseph A Carlucci on 9 June 2020, trading 416,720 units of ARA stock currently worth $533,402.
What does American Renal Associates's logo look like?
Complete history of Mr. Carlucci stock trades at American Renal Associates
American Renal Associates executives and stock owners
American Renal Associates executives and other stock owners filed with the SEC include:
-
Don Williamson,
Chief Operating Officer, Executive Vice President -
Thomas Erickson,
Independent Director -
Joseph Carlucci,
Chairman of the Board, Chief Executive Officer, Co-Founder -
Syed Kamal,
President, Co-Founder, Director -
John Jureller,
Independent Director -
Michael Boxer,
Independent Director -
Robert Fish,
Independent Director -
Christopher Hocevar,
Independent Director -
Jeremy Gelber,
Independent Director -
Darren Lehrich,
SVP Strategy & Investor Relations -
Jared Hendricks,
Independent Director -
Susanne Clark,
Independent Director -
Mark Herbers,
Interim Chief Financial Officer, Interim Chief Accounting Officer -
Jason Boucher,
Former VP & CFO -
Patrick T Ryan,
Director -
John J Mcdonough,
EVP, COO AND TREASURER -
Michael Ray Costa,
VP and General Counsel -
Jonathan L Wilcox,
VP & Chief Financial Officer -
Victoria Labriola,
VP and General Counsel -
Capital Partners L Pcenterb...,